• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    13.95 Down 0.59(4.06%) May 3, 4:00PM EDT
    Prev Close:14.54
    Open:14.26
    Bid:13.50 x 100
    Ask:14.28 x 100
    1y Target Est:20.50
    Beta:1.24532
    Next Earnings Date: 5-May-16CLVS Earnings announcement
    Day's Range:13.90 - 14.57
    52wk Range:12.25 - 116.75
    Volume:559,819
    Avg Vol (3m):1,425,690
    Market Cap:535.48M
    P/E (ttm):N/A
    EPS (ttm):-9.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CLVSDown 4.06%535.48M
    IMMUUp 1.90%355.28M
    THLDDown 3.64%30.32M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-8.60
    Quarterly EPS Est (Mar-16) :-2.39
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback